Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs AbundRX

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and AbundRX head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 230 · Grade C

AbundRX

Visit AbundRX Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 66 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make AbundRX a bad call — it's best for people comparing an itemized self-pay quote after provider review. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
58
Supply Reliability
95
72
Transparency
90
72
Access Breadth
93
50
Clinical Oversight
92
80
Track Record
88
68
CoreAge RxBrief Score 94 · 66AbundRX

Price, coverage & the tracker

CoreAge RxAbundRX
Brief Score94/100 (A)66/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

From $99

Supply period and renewal amount not published for this starting figure.

Full price details

Compounded semaglutide offered; complete selected-plan quote unknown; From $99. Supply period and renewal amount not published for this starting figure.

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

From $149

Supply period and renewal amount not published for this starting figure.

Full price details

Compounded tirzepatide offered; complete selected-plan quote unknown; From $149. Supply period and renewal amount not published for this starting figure.

CoverageUS only; restrictions by state, confirmed at intakeComplete service-state list is not published on the program page.
Brand-name accessNot confirmedNot confirmed
Oral / sublingualInjection onlyInjection only
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

AbundRX: AbundRX lists $99 and $149 starting prices. Its public pages leave the supply period and renewal charge open until the care plan is known.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.